[Effectiveness of the prolonged-action beta-blockader nadolol in the treatment of ischemic heart disease].
Kirichenko
A A
AA
Aslibekian
I S
IS
Ivanova
L N
LN
Zurabian
K M
KM
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D000328:Adult; D002986:Clinical Trials as Topic; D003327:Coronary Disease / Q000188:drug therapy*; D003692:Delayed-Action Preparations; D005500:Follow-Up Studies; D006801:Humans; D008875:Middle Aged; D009248:Nadolol; D011412:Propanolamines / Q000627:therapeutic use*
D000319:Adrenergic beta-Antagonists; D003692:Delayed-Action Preparations; D011412:Propanolamines; D009248:Nadolol
Effektivnost' beta-blokatora prolongirovannogo deĭstviia nadolola pri lechenii ishemicheskoĭ bolezni serdtsa.